Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

UTHRUTHR
Showing 7 of 30 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in UNITED THERAPEUTICS CORP DEL

CITADEL ADVISORS LLC holds 304,692 shares of UTHR (UNITED THERAPEUTICS CORP DEL), worth $165.1M as of 2026-Q2. The position was decreased (-15.5% shares). UTHR represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$165.1M

Current Shares

304,692

Total Value Change

+$157.9M

Total Shares Change

+284,354

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
304,692
-15.5%
$165.1M0.0%$541.83
0
2026-Q1
Increased
360,643
+92.7%
$213.9M0.0%$498.65
49
2025-Q4
Decreased
187,164
-31.7%
$91.2M0.0%$496.19
0
2025-Q3
Increased
273,982
+94.3%
$114.9M0.0%$424.31
48
2025-Q2
Increased
141,011
+289.7%
$40.5M0.0%$284.27
47
2025-Q1
Increased
36,184
+77.9%
$11.2M0.0%$306.97
42
2024-Q4
New
20,338
-
$7.2M0.0%$357.64
38

Other major holders of UTHR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used